Interprofessional Evaluation of a Medication Clinical Decision Support System Prior to Implementation

被引:2
|
作者
Bauer, Jacqueline [1 ,2 ]
Busse, Marika [1 ,2 ]
Kopetzky, Tanja [3 ]
Seggewies, Christof [3 ]
Fromm, Martin F. [4 ,5 ]
Doerje, Frank [1 ,2 ,5 ]
机构
[1] Univ Klinikum Erlangen, Pharm Dept, Palmsanlage 3, D-91054 Erlangen, Germany
[2] Friedrich Alexander Univ Erlangen Nurnberg, Palmsanlage 3, D-91054 Erlangen, Germany
[3] Friedrich Alexander Univ Erlangen Nurnberg, Univ Klinikum Erlangen, Med Ctr Informat & Commun Technol MIK, Erlangen, Germany
[4] Friedrich Alexander Univ Erlangen Nurnberg, Inst Expt & Clin Pharmacol & Toxicol, Erlangen, Germany
[5] Friedrich Alexander Univ Erlangen Nurnberg, FAU NeW Res Ctr New Bioact Cpds, Erlangen, Germany
来源
APPLIED CLINICAL INFORMATICS | 2024年 / 15卷 / 03期
关键词
clinical decision support system; clinical pharmacists; evaluation; medication safety; alert fatigue; PHYSICIAN ORDER ENTRY; DRUG-DRUG INTERACTIONS; ALERTS; PERFORMANCE; ACCEPTANCE; OUTCOMES; EVENTS;
D O I
10.1055/s-0044-1787184
中图分类号
R-058 [];
学科分类号
摘要
Background Computerized physician order entry (CPOE) and clinical decision support systems (CDSS) are widespread due to increasing digitalization of hospitals. They can be associated with reduced medication errors and improved patient safety, but also with well-known risks (e.g., overalerting, nonadoption). Objectives Therefore, we aimed to evaluate a commonly used CDSS containing Medication-Safety-Validators (e.g., drug-drug interactions), which can be locally activated or deactivated, to identify limitations and thereby potentially optimize the use of the CDSS in clinical routine. Methods Within the implementation process of Meona (commercial CPOE/CDSS) at a German University hospital, we conducted an interprofessional evaluation of the CDSS and its included Medication-Safety-Validators following a defined algorithm: (1) general evaluation, (2) systematic technical and content-related validation, (3) decision of activation or deactivation, and possibly (4) choosing the activation mode (interruptive or passive). We completed the in-depth evaluation for exemplarily chosen Medication-Safety-Validators. Moreover, we performed a survey among 12 German University hospitals using Meona to compare their configurations. Results Based on the evaluation, we deactivated 3 of 10 Medication-Safety-Validators due to technical or content-related limitations. For the seven activated Medication-Safety-Validators, we chose the interruptive option ["PUSH-(&PULL)-modus"] four times (4/7), and a new, on-demand option ["only-PULL-modus"] three times (3/7). The site-specific configuration (activation or deactivation) differed across all participating hospitals in the survey and led to varying medication safety alerts for identical patient cases. Conclusion An interprofessional evaluation of CPOE and CDSS prior to implementation in clinical routine is crucial to detect limitations. This can contribute to a sustainable utilization and thereby possibly increase medication safety.
引用
收藏
页码:637 / 649
页数:13
相关论文
共 50 条
  • [31] Evaluation of Medication Safety in Neurological Inpatients Using the Clinical Decision Support Software MediQ
    Guzek, Markus
    Huber, Martin
    Russmann, Stefan
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 : S99 - S99
  • [32] EVALUATION OF MEDICATION-RELATED CLINICAL DECISION SUPPORT OVERRIDES IN THE INTENSIVE CARE UNIT
    Wong, Adrian
    Amato, Mary
    Seger, Diane L.
    Beeler, Patrick E.
    Dalleur, Olivia
    Dykes, Patricia
    Eguale, Tewodros
    Fiskio, Julie
    Silvers, Elizabeth R.
    Slight, Sarah P.
    Bates, David W.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2016, 31 : S217 - S217
  • [33] Assessing the Usability of a Clinical Decision Support System: Heuristic Evaluation
    Cho, Hwayoung
    Keenan, Gail
    Madandola, Olatunde O.
    Dos Santos, Fabiana Cristina
    Macieira, Tamara G. R.
    Bjarnadottir, Ragnhildur, I
    Priola, Karen J. B.
    Lopez, Karen Dunn
    JMIR HUMAN FACTORS, 2022, 9 (02):
  • [34] Clinical Decision Support System for Evaluation of Patients with Musculoskeletal Disorders
    Lopes, Lecian C.
    Barbosa, Sayonara de Fatima F.
    MEDINFO 2019: HEALTH AND WELLBEING E-NETWORKS FOR ALL, 2019, 264 : 1633 - 1634
  • [35] Prospective Evaluation of a Clinical Decision Support System in Psychological Therapy
    Lutz, Wolfgang
    Deisenhofer, Anne-Katharina
    Rubel, Julian
    Bennemann, Bjoern
    Giesemann, Julia
    Poster, Kaitlyn
    Schwartz, Brian
    JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 2022, 90 (01) : 90 - 106
  • [36] Evaluation of a semi-automated clinical decision support system
    Dahmke, H.
    Fiumefreddo, R.
    Zaugg, C.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2022, 44 (06) : 1472 - 1472
  • [37] Design and implementation of a high-risk medication decision support system for hospitalized geriatric patients
    Marvanova, Marketa
    Peterson, Josh
    Kripalani, Sunil
    Danciu, Ionna
    Harrell, Debbie
    Rodriguez, Carmen
    Powers, James
    PHARMACOTHERAPY, 2013, 33 (05): : E55 - E55
  • [38] Implementation and Evaluation of Clinical Decision Support for Apixaban Dosing in a Community Teaching Hospital
    Cope, Rebecca
    Sarsour, Maram
    Sasson, Evan
    Badran, Hasan
    Kim, Ka Yeun
    Quinn, Rachel
    JOURNAL OF PATIENT SAFETY, 2024, 20 (07) : 474 - 477
  • [39] Extubation Advisor: Implementation and Evaluation of A Novel Extubation Clinical Decision Support Tool
    Hryciw, Brett N.
    Hudek, Natasha
    Brehaut, Jamie C.
    Herry, Christophe
    Scales, Nathan
    Lee, Emma
    Sarti, Aimee J.
    Burns, Karen E. A.
    Seely, Andrew J. E.
    JOURNAL OF INTENSIVE CARE MEDICINE, 2024,
  • [40] Improving medication-related clinical decision support
    Tolley, Clare L.
    Slight, Sarah P.
    Husband, Andrew K.
    Watson, Neil
    Bates, David W.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2018, 75 (04) : 239 - 246